GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › EYPT growth analysis
Growth stock analysis · updated 2026-07-28

EyePoint, Inc. Common Stock (EYPT) growth stock analysis

Is EyePoint, Inc. Common Stock a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
28
Growth score
35
RS rating
#3,127
Rank
1/6
Traits passed
28/99
Growth score · 3127th of 4,892 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about EYPT

As of the 2026-07-28 close, EYPT scores 28 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 3127th of 4,892 rated US stocks, the top 64% of the market.

Its strongest trait is I (institutional sponsorship) at 60, and its weakest is A (annual earnings growth) at 0. EYPT clears 1 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, EYPT carries a lagging Relative Strength rating of 35, meaning it has outperformed about 35% of the market over the past year.

Underneath the score: sales down 97%, trading 37% below its 52-week high, volume running 1.3× its 50-day average.

EYPT growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
22
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
0
S
Supply & demand
volume behind the move vs. share supply
51
L
Leader or laggard
Relative Strength within its group
31
I
Institutional sponsorship
fund accumulation and 13F ownership
60

Is EYPT a growth stock?

Not right now by CANSLIM

On today’s data EYPT does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than EYPT

The stocks ranking above EYPT today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 EYPT price history & buy range

Where EYPT sits in its base, its 52-week path, and the trait trend over the past year.

Open the full EYPT profile →

See where EYPT ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

EYPT as a growth stock, frequently asked

Is EYPT a good growth stock?

Not right now by CANSLIM. On today’s data EYPT does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is EYPT's growth score?

EyePoint, Inc. Common Stock (EYPT) scores 28 out of 99 on our growth-stock rating as of the 2026-07-28 close, ranking 3127th of 4,892 rated US stocks.

Does EYPT have strong earnings growth?

We don't have current earnings-growth figures for EYPT.

How strong is EYPT's price performance?

EYPT has a Relative Strength rating of 35, meaning it has outperformed roughly 35% of the US market over the trailing year.

Where can I see EYPT's full analysis?

Create a free Growth Stock Analyzer account to see where EYPT ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Laboratory Analytical Instruments